Tilray Stock Is Trading Higher Tuesday: Here's Why
Tilray Stock Is Trading Higher Tuesday: Here's Why
Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher Tuesday after the company reported better-than-expected financial results for the fourth quarter.
Tilray Brands Inc (纳斯达克:TLRY)的股票周二高开，该公司发布了超预期的第四季度财报。
- Q4 Revenue: $229.882 million, versus estimates of $227.07 million
- 第四季度营业收入：2.29882亿美元，预估值为2.2707亿美元。
- Q4 EPS: 4 cents, versus estimates for a loss of 2 cents
- 第四季度每股收益：4美分，预估为每股亏损2美分。
Total revenue was up approximately 25% on a year-over-year basis. Cannabis net revenue jumped 12% to $71.9 million in the quarter, while beverage-alcohol net revenue increased 137% to $76.7 million. Distribution net revenue fell to $65.6 million in the fourth quarter and Wellness net revenue increased 6% to $15.7 million.
总营业收入同比增长约25%。第四季度大麻净收入增长12%，为7190万美元，而饮料酒类净收入增长137%，为7670万美元。配送净收入为6560万美元，第四季度保健净收入增长6%，为1570万美元。
Gross profit came in at $82.4 million in the fourth quarter. Gross margin and adjusted gross margin was 36%. Adjusted EBITDA increased 37% year-over-year to $29.5 million in the fourth quarter. Tilray noted that it reduced its net convertible debt by about $300 million in fiscal 2024.
第四季度毛利润为8240万美元。毛利率和调整后的毛利率为36%。调整后的税息折旧及摊销前利润同比增长37%，至2950万美元。Tilray指出，其在2024财年中约减了净可转换债务30000万美元。
"Tilray Brands is leading the convergence of cannabis, beverages, and wellness on a global scale," said Irwin Simon, chairman and CEO of Tilray Brands.
“Tilray品牌正引领全球范围大麻、饮料和健康领域的融合，” Tilray品牌董事长兼CEO Irwin Simon表示。
"In Fiscal 2024, the Company achieved remarkable growth across its businesses, with a 26% increase in net revenue over the prior year, record-breaking performance in gross profit and adjusted EBITDA, and generated positive adjusted free cash flow for the fiscal year. We have also significantly reduced our net convertible debt by ~$300 million and surpassed our cost-savings synergy target, which has strengthened our balance sheet."
“在财年2024中，公司的业绩创造了惊人的增长，净收入同比增长26%，毛利润和调整后的税息折旧及摊销前利润均创纪录，而且财年调整后自由现金流为正。我们还大幅减少了约30000万美元的净可转换债务，并超过了成本节约协同效应目标，这增强了我们的资产负债表。”
Following the print, Zuanic & Associates senior analyst Pablo Zuanic maintained a Neutral rating on Tilray shares, but noted that the stock should be a long-term holding in global cannabis portfolios.
Zuanic & Associates高级分析师Pablo Zuanic在公布这一业绩后维持了对Tilray股票的中立评级，但指出该股票应为在全球大麻组合中的长期持仓。
TLRY Price Action: Tilray shares were up 7.65% at $1.97 at the time of publication, according to Benzinga Pro.
截至发布时，Tilray的股票上涨了7.65%，报1.97美元，根据Benzinga Pro的数据。
Photo: iQoncept via Shutterstock.
图片：iQoncept通过shutterstock。